| Literature DB >> 34071715 |
Ruixia Chen1,2, Dequan Zhang1,2, Huan Liu1,2, Zhenyu Wang1,2, Teng Hui1,2.
Abstract
Reducing or replacing sodium nitrite without compromising the sensory attributes of meat products has always been a focus of the meat industry. In this study, five treatments, CT (without nitrite and plasma treatment), NT (with nitrite treatment), PT15, PT30, and PT45 (without nitrite and with plasma treatment for 15, 30, and 45 min, respectively), were designed to investigate the effect of atmospheric nonthermal plasma treatment replacing nitrite on the sensory attributes of roasted lamb. Results showed that PT45 decreased the residual nitrite of roasted lamb by 30% compared with NT, and nitrite was not detected in the PT15 and PT30 samples. The inhibition effect of plasma treatment on the lipid oxidation reached values from 86.69% to 89.89% compared with NT. Compared with CT, the redness of plasma-treated samples was increased by 9.30% to 31.40%, and the redness of NT samples was increased by 30.87%. In addition, the volatile compounds (OAVs > 1) of the PT30 sample were higher than those of the NT sample. The overall sensory score of the PT30 sample was higher than that of the CT sample and was similar to that of the NT samples. In conclusion, the sensory attributes of roasted lamb were enhanced by plasma treatment, and the 30 min plasma treatment is recommended.Entities:
Keywords: atmospheric nonthermal plasma; nitrite; roasted lamb; sensory attribute; volatile compound
Year: 2021 PMID: 34071715 PMCID: PMC8229768 DOI: 10.3390/foods10061234
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Experimental design: salt, onion, egg white, and sodium nitrite (in percentage of meat weight) used for meat samples.
| Treatment Groups a | CT | NT | PT15 | PT30 | PT45 |
|---|---|---|---|---|---|
| Salt | 1% | 1% | 1% | 1% | 1% |
| Onion | 10% | 10% | 10% | 10% | 10% |
| Egg white | 3.5% | 3.5% | 3.5% | 3.5% | 3.5% |
| Nitrite sodium | - | 0.005% | - | - | - |
| Plasma treatment time | - | - | 15 min | 30 min | 45 min |
a Treatment groups: Control group (CT): without sodium nitrite and plasma treatment; NT: with 0.005% sodium nitrite; PT15: with plasma treatment for 15 min; PT30: with plasma treatment for 30 min; PT45: with plasma treatment for 45 min.
Changes in nitrite content (mg/kg) in roasted lamb.
| CT | NT | PT15 | PT30 | PT45 | |
|---|---|---|---|---|---|
| Nitrite content (mg/kg) | ND | 2.66 ± 0.82 a | ND | ND | 1.88 ± 0.59 b |
a,b Mean values in the same row followed by different letters are significantly different (p < 0.05). ND: Not detected; Control group (CT): without sodium nitrite and plasma treatment; NT: with 0.005% sodium nitrite; PT15: with plasma treatment for 15 min; PT30: with plasma treatment for 30 min; PT45: with plasma treatment for 45 min.
Figure 1Changes in the content of sulfhydryl (A) and TBARS value (B) of roasted lamb with different treatments. a, b, c Mean values with different letters are significantly different (p < 0.05). Control group (CT): without sodium nitrite and plasma treatment; NT: with 0.005% sodium nitrite; PT15: with plasma treatment for 15 min; PT30: with plasma treatment for 30 min; PT45: with plasma treatment for 45 min.
Figure 2Changes in colour (L*-(A), a*-(B), b*-(C)) and shear force value (D) of roasted lamb with different treatments. a, b, c Mean values with different letters are significantly different (p < 0.05). Control group (CT): without sodium nitrite and plasma treatment; NT: with 0.005% nitrite sodium; PT15: with plasma treatment for 15 min; PT30: with plasma treatment for 30 min; PT45: with plasma treatment for 45 min.
Changes in volatile compound content (ng/g) in roasted lamb.
| LRI a | Identification d | CT | NT | PT15 | PT30 | PT45 | ||
|---|---|---|---|---|---|---|---|---|
| Literature b | Calculated c | |||||||
| Aldehydes | ||||||||
| Hexanal | 1073 | 1077 | MS + LRI | 2773.56 ± 423.64 a | ND | 131.09 ± 41.18 c | 1572.25 ± 120.73 b | 224.03 ± 39.84 c |
| Heptanal | 1163 | 1180 | MS + LRI | 786.22 ± 270.82 a | ND | ND | 345.23 ± 2.18 b | ND |
| Octanal | 1275 | 1283 | MS + LRI | 484.85 ± 136.37 a | 20.36 ± 6.54 c | ND | 252.42 ± 20.73 b | 91.30 ± 7.52 c |
| (E)-2-Heptenal | 1334 | 1311 | MS + LRI | 17.25 ± 6.05 | ND | ND | ND | ND |
| Nonanal | 1385 | 1387 | MS + LRI | 826.55 ± 159.97 a | 47.40 ± 11.09 d | 192.82 ± 33.86 c | 483.55 ± 16.69 b | 232.68 ± 21.39 c |
| (E)-2-Octenal | 1416 | 1419 | MS + LRI | 38.28 ± 10.28 a | ND | ND | 16.37 ± 7.92 b | ND |
| Decanal | 1483 | 1492 | MS + LRI | 11.71 ± 0.33 a | ND | 1.95 ± 0.39 d | 10.40 ± 0.88 b | 4.39 ± 0.43 c |
| Benzaldehyde | 1508 | 1506 | MS + LRI | 43.30 ± 5.40 a | 28.75 ± 6.81 b | 31.55 ± 4.69 b | 36.15 ± 2.23 ab | 30.27 ± 2.28 b |
| (E)-2-Nonenal | 1535 | 1526 | MS + LRI | 28.57 ± 7.64 a | ND | ND | 14.50 ± 5.24 b | ND |
| Dodecanal | 1710 | 1704 | MS + LRI | 6.24 ± 1.23 a | ND | ND | 4.47 ± 0.87 b | ND |
| 2-Undecenal | 1755 | 1745 | MS + LRI | 7.98 ± 2.23 | ND | ND | ND | ND |
| (E,E)-2,4-Decadienal | 1766 | 1757 | MS + LRI | 11.12 ± 2.80 | ND | ND | ND | ND |
| Myristaldehyde | 1931 | 1918 | MS + LRI | 8.77 ± 2.79 a | ND | ND | 4.27 ± 1.00 b | ND |
| Pentadecanal | 2042 | 2025 | MS + LRI | 11.86 ± 4.29 a | ND | 1.32 ± 0.70 b | 7.19 ± 3.14 a | ND |
| Hexadecanal | 2141 | 2132 | MS + LRI | 4.41 ± 0.34 a | ND | 2.36 ± 0.43 b | 4.22 ± 0.35 a | 1.90 ± 0.27 b |
|
| ||||||||
| Pentanol | 1252 | 1250 | MS + LRI | 177.44 ± 30.82 a | ND | 7.62 ± 1.74 c | 77.33 ± 12.57 b | 9.84 ± 1.83 c |
| Hexanol | 1344 | 1352 | MS + LRI | 45.99 ± 8.11 a | ND | 4.80 ± 0.72 c | 33.02 ± 10.66 b | 5.74 ± 1.46 c |
| Propyl disulfide | 1378 | 1369 | MS + LRI | 26.31 ± 4.54 b | 63.9 ± 18.74 a | ND | 46.30 ± 3.39 a | 4.29 ± 0.70 c |
| 1-Octen-3-ol | 1430 | 1449 | MS + LRI | 433.01 ± 89.65 a | 15.58 ± 4.35 c | 42.73 ± 8.22 c | 202.97 ± 17.34 b | 57.32 ± 8.22 c |
| Heptanol | 1456 | 1454 | MS + LRI | 46.41 ± 8.66 a | ND | ND | 24.57 ± 2.51 b | ND |
| 2-Ethyl-1-hexanol | 1484 | 1488 | MS + LRI | ND | ND | ND | 4.07 ± 0.41 | ND |
| Octanol | 1554 | 1556 | MS + LRI | 48.19 ± 13.49 a | 2.50 ± 0.74 c | 9.07 ± 1.38 c | 26.34 ± 2.17 b | 12.36 ± 0.97 c |
| (E)-2-Octen-1-ol | 1620 | 1613 | MS + LRI | 51.71 ± 11.01 a | 1.85 ± 0.51 c | 4.66 ± 0.68 c | 22.16 ± 2.96 b | 6.66 ± 0.72c |
|
| ||||||||
| 3-Hydroxy-2-butanone | 1280 | 1273 | MS + LRI | 115.51 ± 18.81 a | 56.61 ± 16.32 b | 110.85 ± 18.59 a | 59.86 ± 5.69 b | 48.70 ± 4.52 b |
| 2,3-Octanedione | 1325 | 1321 | MS + LRI | 1373.31 ± 292.40 a | ND | 48.19 ± 18.95 c | 645.8 ± 45.51 b | 80.81 ± 20.84 c |
| 6-Methyl-5-heptene-2-one | 1340 | 1328 | MS + LRI | ND | ND | 2.80 ± 0.09 b | 6.29 ± 0.74 a | ND |
|
| ||||||||
| 2,5-Dimethylpyrazine | 1325 | 1314 | MS + LRI | ND | 22.27 ± 7.51 a | ND | 14.22 ± 2.72 b | 14.25 ± 1.53 b |
| 2-Methyl-6-ethylpyrazine | 1393 | 1382 | MS + LRI | ND | 8.80 ± 5.27 a | 3.48 ± 0.23 b | 3.89 ± 0.74 b | 8.88 ± 1.48 a |
| 2,3,5-Trimethylpyrazine | 1408 | 1395 | MS + LRI | 18.68 ± 4.23 | 18.89 ± 6.70 | 15.22 ± 2.26 | 12.87 ± 1.48 | 17.97 ± 2.42 |
| 2-Ethyl-3,5-dimethylpyrazine | 1443 | 1438 | MS + LRI | 8.09 ± 4.37 ab | 13.40 ± 3.89 a | 10.15 ± 1.24 ab | 6.24 ± 0.36 b | 9.49 ± 1.56 ab |
|
| ||||||||
| Butanoic acid | 1625 | 1621 | MS + LRI | ND | 7.63 ± 2.33 b | 13.94 ± 2.52 a | ND | 11.73 ± 1.42 a |
| Hexanoic acid | 1850 | 1839 | MS + LRI | 45.58 ± 15.17 a | 5.41 ± 1.51 c | 10.42 ± 1.40 c | 25.97 ± 6.43 b | 12.05 ± 1.32 c |
|
| ||||||||
| 2-Pentylfuran | 1235 | 1228 | MS + LRI | 103.49 ± 23.50 a | ND | 13.25 ± 3.65 c | 59.97 ± 7.54 b | 19.16 ± 1.07 c |
| Butyrolactone | 1615 | 1606 | MS + LRI | 4.74 ± 1.45 a | 3.96 ± 1.07 ab | 5.11 ± 0.59 a | 2.92 ± 0.11 b | 4.58 ± 0.52 ab |
| 2-Acetylpyrrole | 1972 | 1960 | MS + LRI | 2.74 ± 0.59 a | 1.90 ± 0.60 b | 2.02 ± 0.22 ab | 2.32 ± 0.14 ab | 1.67 ± 0.17 b |
a, b,c Mean values in the same row followed by different letters are significantly different (p < 0.05). a Linear retention index. b Reported date. c Calculated data based on n-alkanes (C7–C40). d Reliability of identification. MS: volatile compounds tentatively identified by comparing their mass spectra with those contained in the MS library; LRI: volatile compounds tentatively identified by comparing their LRI with those reported in the literature; ND: Not detected; Control group (CT): without sodium nitrite and plasma treatment; NT: with 0.005% sodium nitrite; PT15: with plasma treatment for 15 min; PT30: with plasma treatment for 30 min; PT45: with plasma treatment for 45 min.
Figure 3A heatmap (A) displaying the OAVs of volatile compounds (OAVs > 1) of roasted lamb, and an OPLS-DA score plot (B) displaying the comparison of volatile compounds (OAVs > 1) in roasted lamb with different treatments. Control group (CT): without sodium nitrite and plasma treatment; NT: with 0.005% sodium nitrite; PT15: with plasma treatment for 15 min; PT30: with plasma treatment for 30 min; PT45: with plasma treatment for 45 min.
Figure 4Radar (A) displaying the sensory scores of lamb odour, roasted flavour, colour, tenderness, juiciness, and overall acceptance in roasted lamb and OPLS-DA bioplot (B) displaying the comparison of sensory scores in roasted lamb with different treatments. Control group (CT): without sodium nitrite and plasma treatment; NT: with 0.005% sodium nitrite; PT15: with plasma treatment for 15 min; PT30: with plasma treatment for 30 min; PT45: with plasma treatment for 45 min.
The sensory score of lamb odour, roasted flavour, colour, tenderness, juiciness, and overall acceptance in roasted lamb.
| Colour | Lamb Odour | Tenderness | Juiciness | Roasted Flavour | Overall Acceptance | |
|---|---|---|---|---|---|---|
| CT | 4.27 ± 1.39 a | 4.30 ± 2.04 a | 6.18 ± 1.32 a | 7.17 ± 1.61 b | 5.68 ± 1.43 a | 5.62 ± 1.37 ab |
| NT | 6.60 ± 1.82 b | 3.79 ± 2.12 a | 5.16 ± 1.62 a | 5.78 ± 1.50 a | 6.62 ± 1.05 a | 6.42 ± 0.90 b |
| PT15 | 4.28 ± 1.98 a | 3.87 ± 2.09 a | 5.41 ± 1.49 a | 5.51 ± 1.34 a | 5.86 ± 1.57 a | 5.20 ± 1.82 a |
| PT30 | 5.60 ± 1.55 ab | 3.90 ± 1.87 a | 5.98 ± 1.63 a | 6.06 ± 1.60 ab | 6.38 ± 1.11 a | 6.07 ± 1.27 ab |
| PT45 | 6.04 ± 1.05 b | 3.23 ± 1.71 a | 5.32 ± 1.21 a | 5.18 ± 1.77 a | 6.35 ± 1.31 a | 6.11 ± 0.93 ab |
a,b Mean values in the same column followed by different letters are significantly different (p < 0.05). Control group (CT): without sodium nitrite and plasma treatment; NT: with 0.005% sodium nitrite; PT15: with plasma treatment for 15 min; PT30: with plasma treatment for 30 min; PT45: with plasma treatment for 45 min.